FDA News 2012 (40 Articles)


Late breaking and archival record of updates on safety and regulatory issues related to HIV/AIDS information from the FDA Office of Special Health Issues (Office of the Commissioner) and the Division of Antiviral Drug Products (Center for Drug Evaluation and Research). Information includes: product approvals, significant labeling changes, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.